{"nct_id":"NCT01934127","title":"Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2013-08-26","start_date_type":"ACTUAL","primary_completion_date":"2013-11-01","primary_completion_date_type":"ACTUAL","completion_date":"2014-10-20","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}